Study suggests potential hurdle to universal flu vaccine development may be overcome

In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing immunity generated by prior exposure to influenza virus or vaccine hamper production of broadly neutralizing antibodies? If so, then a universal flu vaccine might work best (and perhaps only) in very young children who have had limited exposure to influenza viruses or vaccines.

Now, in studies using mice and ferrets, investigators from the Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown that broadly neutralizing influenza antibodies can indeed be elicited by a prime-boost vaccine regimen, even when the animals had pre-existing immunity to influenza.

The vaccine regimen consisted of a DNA vaccine prime followed by boosting with an inactivated seasonal vaccine. It did not matter if the pre-existing immunity was due to exposure to a flu virus or if it followed vaccination with standard seasonal . Influenza-immune ferrets inoculated with the prime-boost regimen were protected against challenge with unmatched virus strains.

If the same effect is found in studies in people, it might be possible to develop vaccines that give long-lasting flu protection to people of all ages, according to the researchers.

Several clinical trials to examine the ability of first-generation universal flu vaccines to generate broadly are either under way or planned at the VRC.

More information: C-H Wei et al. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure. Science Translational Medicine DOI: 10.1126/scitranslmed.3004273 (2012).

Related Stories

Priming with DNA vaccine makes avian flu vaccine work better

Oct 03, 2011

The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say. Their report describes ...

Scientists advance universal flu vaccine

Jul 15, 2010

A universal influenza vaccine - so-called because it could potentially provide protection from all flu strains for decades - may become a reality because of research led by scientists from the National Institute of Allergy ...

NIH experts describe influenza vaccines of the future

Nov 17, 2010

In a review article appearing in the New England Journal of Medicine, scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine research under way to ...

Recommended for you

$1,000 pill now hepatitis C treatment of choice

7 hours ago

(AP)—A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.

User comments